HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mian Xi Selected Research

Esophageal Fistula

10/2022Risk factors and prognosis for esophageal fistula in patients with esophageal squamous cell carcinoma during radiotherapy.
1/2021High incidence of esophageal fistula on patients with clinical T4b esophageal squamous cell carcinoma who received chemoradiotherapy: A retrospective analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mian Xi Research Topics

Disease

29Esophageal Squamous Cell Carcinoma
10/2022 - 08/2012
15Esophageal Neoplasms (Esophageal Cancer)
01/2020 - 11/2014
14Neoplasms (Cancer)
03/2022 - 01/2007
8Hepatocellular Carcinoma (Hepatoma)
01/2020 - 01/2011
7Pathologic Complete Response
01/2021 - 08/2015
5Neoplasm Metastasis (Metastasis)
01/2018 - 01/2014
4Adenocarcinoma
01/2019 - 11/2017
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2017 - 01/2014
4Nasopharyngeal Carcinoma
07/2017 - 12/2010
3Squamous Cell Neoplasms (Squamous Cell Cancer)
10/2022 - 01/2016
2Esophageal Fistula
10/2022 - 01/2021
2Radiation Pneumonitis
10/2021 - 01/2020
2Lymphopenia (Lymphocytopenia)
01/2021 - 09/2019
2Carcinoma (Carcinomatosis)
07/2017 - 11/2014
1Fistula
10/2022
1Residual Neoplasm
01/2020
1Tongue Neoplasms (Tongue Neoplasm)
07/2017
1Fibrosarcoma
02/2017
1Leukopenia
08/2015
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2015
1Lymphatic Metastasis
09/2012

Drug/Important Bio-Agent (IBA)

5Cisplatin (Platino)FDA LinkGeneric
01/2020 - 08/2012
5Insulin-Like Growth Factor Binding Protein 3IBA
12/2015 - 08/2012
4Fluorouracil (Carac)FDA LinkGeneric
01/2020 - 08/2015
4Insulin-Like PeptidesIBA
12/2015 - 12/2012
3Biomarkers (Surrogate Marker)IBA
01/2021 - 11/2017
2Proteins (Proteins, Gene)FDA Link
03/2022 - 09/2015
2Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
01/2020 - 02/2019
2LigandsIBA
01/2020 - 02/2019
2Sorafenib (BAY 43-9006)FDA Link
12/2018 - 10/2012
2Docetaxel (Taxotere)FDA Link
08/2017 - 07/2016
2nimotuzumabIBA
12/2012 - 08/2012
1Serum AlbuminIBA
10/2022
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
11/2017
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2017
1vasectrin IIIIBA
11/2015
1Long Noncoding RNAIBA
11/2015
1Vinorelbine (Navelbine)FDA LinkGeneric
08/2015
1Cadherins (E-Cadherin)IBA
01/2015
1ErbB Receptors (EGF Receptor)IBA
12/2012
1ParaffinIBA
12/2012

Therapy/Procedure

17Chemoradiotherapy
10/2021 - 01/2014
16Radiotherapy
10/2022 - 08/2009
14Neoadjuvant Therapy
01/2021 - 08/2015
6Therapeutics
10/2022 - 01/2017
5Esophagectomy
10/2021 - 11/2017
5Induction Chemotherapy
01/2021 - 01/2017
5Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
01/2020 - 09/2012
3Conformal Radiotherapy
01/2020 - 01/2007
3Radiofrequency Ablation
01/2020 - 08/2019
3Drug Therapy (Chemotherapy)
01/2020 - 07/2016
2Salvage Therapy
01/2020 - 08/2019
2Proton Therapy
11/2017 - 01/2017
1Aftercare (After-Treatment)
01/2018